Report Detail

Pharma & Healthcare Global IVIG Market Insights and Forecast to 2026

  • RnM4150369
  • |
  • 21 August, 2020
  • |
  • Global
  • |
  • 151 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

IVIG market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global IVIG market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the IVIG market is segmented into
Injection
Lyophilized Powder

Segment by Application, the IVIG market is segmented into
Multiple Sclerosis (MS)
Myasthenia Gravis (MG)
Multifocal Motor Neuropathy (MMN)
Multifocal Acquired Sensory and Motor Neuropathy (MADSAM)
Dermatomyositis
Polymyositis

Regional and Country-level Analysis
The IVIG market is analysed and market size information is provided by regions (countries).
The key regions covered in the IVIG market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and IVIG Market Share Analysis
IVIG market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in IVIG business, the date to enter into the IVIG market, IVIG product introduction, recent developments, etc.

The major vendors covered:
Green Cross
BSV
Hualan Bio
RAAS
YUAN DA SHUYANG
Kangbao Bio
Tiantan Bio
Taibang Bio
Weiguang Bio
SIBP
TONROL
RUIDE Bio
BOYA Bio
RUIDE Bio
Xinxing Medicine
Weilun Bio
WIBP


1 Study Coverage

  • 1.1 IVIG Product Introduction
  • 1.2 Market Segments
  • 1.3 Key IVIG Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global IVIG Market Size Growth Rate by Type
    • 1.4.2 Injection
    • 1.4.3 Lyophilized Powder
  • 1.5 Market by Application
    • 1.5.1 Global IVIG Market Size Growth Rate by Application
    • 1.5.2 Multiple Sclerosis (MS)
    • 1.5.3 Myasthenia Gravis (MG)
    • 1.5.4 Multifocal Motor Neuropathy (MMN)
    • 1.5.5 Multifocal Acquired Sensory and Motor Neuropathy (MADSAM)
    • 1.5.6 Dermatomyositis
    • 1.5.7 Polymyositis
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global IVIG Market Size, Estimates and Forecasts
    • 2.1.1 Global IVIG Revenue 2015-2026
    • 2.1.2 Global IVIG Sales 2015-2026
  • 2.2 Global IVIG, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global IVIG Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global IVIG Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global IVIG Competitor Landscape by Players

  • 3.1 IVIG Sales by Manufacturers
    • 3.1.1 IVIG Sales by Manufacturers (2015-2020)
    • 3.1.2 IVIG Sales Market Share by Manufacturers (2015-2020)
  • 3.2 IVIG Revenue by Manufacturers
    • 3.2.1 IVIG Revenue by Manufacturers (2015-2020)
    • 3.2.2 IVIG Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global IVIG Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by IVIG Revenue in 2019
    • 3.2.5 Global IVIG Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 IVIG Price by Manufacturers
  • 3.4 IVIG Manufacturing Base Distribution, Product Types
    • 3.4.1 IVIG Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers IVIG Product Type
    • 3.4.3 Date of International Manufacturers Enter into IVIG Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global IVIG Market Size by Type (2015-2020)
    • 4.1.1 Global IVIG Sales by Type (2015-2020)
    • 4.1.2 Global IVIG Revenue by Type (2015-2020)
    • 4.1.3 IVIG Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global IVIG Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global IVIG Sales Forecast by Type (2021-2026)
    • 4.2.2 Global IVIG Revenue Forecast by Type (2021-2026)
    • 4.2.3 IVIG Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global IVIG Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global IVIG Market Size by Application (2015-2020)
    • 5.1.1 Global IVIG Sales by Application (2015-2020)
    • 5.1.2 Global IVIG Revenue by Application (2015-2020)
    • 5.1.3 IVIG Price by Application (2015-2020)
  • 5.2 IVIG Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global IVIG Sales Forecast by Application (2021-2026)
    • 5.2.2 Global IVIG Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global IVIG Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America IVIG by Country
    • 6.1.1 North America IVIG Sales by Country
    • 6.1.2 North America IVIG Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America IVIG Market Facts & Figures by Type
  • 6.3 North America IVIG Market Facts & Figures by Application

7 Europe

  • 7.1 Europe IVIG by Country
    • 7.1.1 Europe IVIG Sales by Country
    • 7.1.2 Europe IVIG Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe IVIG Market Facts & Figures by Type
  • 7.3 Europe IVIG Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific IVIG by Region
    • 8.1.1 Asia Pacific IVIG Sales by Region
    • 8.1.2 Asia Pacific IVIG Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific IVIG Market Facts & Figures by Type
  • 8.3 Asia Pacific IVIG Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America IVIG by Country
    • 9.1.1 Latin America IVIG Sales by Country
    • 9.1.2 Latin America IVIG Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America IVIG Market Facts & Figures by Type
  • 9.3 Central & South America IVIG Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa IVIG by Country
    • 10.1.1 Middle East and Africa IVIG Sales by Country
    • 10.1.2 Middle East and Africa IVIG Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa IVIG Market Facts & Figures by Type
  • 10.3 Middle East and Africa IVIG Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Green Cross
    • 11.1.1 Green Cross Corporation Information
    • 11.1.2 Green Cross Description and Business Overview
    • 11.1.3 Green Cross Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Green Cross IVIG Products Offered
    • 11.1.5 Green Cross Related Developments
  • 11.2 BSV
    • 11.2.1 BSV Corporation Information
    • 11.2.2 BSV Description and Business Overview
    • 11.2.3 BSV Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 BSV IVIG Products Offered
    • 11.2.5 BSV Related Developments
  • 11.3 Hualan Bio
    • 11.3.1 Hualan Bio Corporation Information
    • 11.3.2 Hualan Bio Description and Business Overview
    • 11.3.3 Hualan Bio Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Hualan Bio IVIG Products Offered
    • 11.3.5 Hualan Bio Related Developments
  • 11.4 RAAS
    • 11.4.1 RAAS Corporation Information
    • 11.4.2 RAAS Description and Business Overview
    • 11.4.3 RAAS Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 RAAS IVIG Products Offered
    • 11.4.5 RAAS Related Developments
  • 11.5 YUAN DA SHUYANG
    • 11.5.1 YUAN DA SHUYANG Corporation Information
    • 11.5.2 YUAN DA SHUYANG Description and Business Overview
    • 11.5.3 YUAN DA SHUYANG Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 YUAN DA SHUYANG IVIG Products Offered
    • 11.5.5 YUAN DA SHUYANG Related Developments
  • 11.6 Kangbao Bio
    • 11.6.1 Kangbao Bio Corporation Information
    • 11.6.2 Kangbao Bio Description and Business Overview
    • 11.6.3 Kangbao Bio Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Kangbao Bio IVIG Products Offered
    • 11.6.5 Kangbao Bio Related Developments
  • 11.7 Tiantan Bio
    • 11.7.1 Tiantan Bio Corporation Information
    • 11.7.2 Tiantan Bio Description and Business Overview
    • 11.7.3 Tiantan Bio Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Tiantan Bio IVIG Products Offered
    • 11.7.5 Tiantan Bio Related Developments
  • 11.8 Taibang Bio
    • 11.8.1 Taibang Bio Corporation Information
    • 11.8.2 Taibang Bio Description and Business Overview
    • 11.8.3 Taibang Bio Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Taibang Bio IVIG Products Offered
    • 11.8.5 Taibang Bio Related Developments
  • 11.9 Weiguang Bio
    • 11.9.1 Weiguang Bio Corporation Information
    • 11.9.2 Weiguang Bio Description and Business Overview
    • 11.9.3 Weiguang Bio Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Weiguang Bio IVIG Products Offered
    • 11.9.5 Weiguang Bio Related Developments
  • 11.10 SIBP
    • 11.10.1 SIBP Corporation Information
    • 11.10.2 SIBP Description and Business Overview
    • 11.10.3 SIBP Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 SIBP IVIG Products Offered
    • 11.10.5 SIBP Related Developments
  • 11.1 Green Cross
    • 11.1.1 Green Cross Corporation Information
    • 11.1.2 Green Cross Description and Business Overview
    • 11.1.3 Green Cross Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Green Cross IVIG Products Offered
    • 11.1.5 Green Cross Related Developments
  • 11.12 RUIDE Bio
    • 11.12.1 RUIDE Bio Corporation Information
    • 11.12.2 RUIDE Bio Description and Business Overview
    • 11.12.3 RUIDE Bio Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 RUIDE Bio Products Offered
    • 11.12.5 RUIDE Bio Related Developments
  • 11.13 BOYA Bio
    • 11.13.1 BOYA Bio Corporation Information
    • 11.13.2 BOYA Bio Description and Business Overview
    • 11.13.3 BOYA Bio Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 BOYA Bio Products Offered
    • 11.13.5 BOYA Bio Related Developments
  • 11.14 RUIDE Bio
    • 11.14.1 RUIDE Bio Corporation Information
    • 11.14.2 RUIDE Bio Description and Business Overview
    • 11.14.3 RUIDE Bio Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 RUIDE Bio Products Offered
    • 11.14.5 RUIDE Bio Related Developments
  • 11.15 Xinxing Medicine
    • 11.15.1 Xinxing Medicine Corporation Information
    • 11.15.2 Xinxing Medicine Description and Business Overview
    • 11.15.3 Xinxing Medicine Sales, Revenue and Gross Margin (2015-2020)
    • 11.15.4 Xinxing Medicine Products Offered
    • 11.15.5 Xinxing Medicine Related Developments
  • 11.16 Weilun Bio
    • 11.16.1 Weilun Bio Corporation Information
    • 11.16.2 Weilun Bio Description and Business Overview
    • 11.16.3 Weilun Bio Sales, Revenue and Gross Margin (2015-2020)
    • 11.16.4 Weilun Bio Products Offered
    • 11.16.5 Weilun Bio Related Developments
  • 11.17 WIBP
    • 11.17.1 WIBP Corporation Information
    • 11.17.2 WIBP Description and Business Overview
    • 11.17.3 WIBP Sales, Revenue and Gross Margin (2015-2020)
    • 11.17.4 WIBP Products Offered
    • 11.17.5 WIBP Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 IVIG Market Estimates and Projections by Region
    • 12.1.1 Global IVIG Sales Forecast by Regions 2021-2026
    • 12.1.2 Global IVIG Revenue Forecast by Regions 2021-2026
  • 12.2 North America IVIG Market Size Forecast (2021-2026)
    • 12.2.1 North America: IVIG Sales Forecast (2021-2026)
    • 12.2.2 North America: IVIG Revenue Forecast (2021-2026)
    • 12.2.3 North America: IVIG Market Size Forecast by Country (2021-2026)
  • 12.3 Europe IVIG Market Size Forecast (2021-2026)
    • 12.3.1 Europe: IVIG Sales Forecast (2021-2026)
    • 12.3.2 Europe: IVIG Revenue Forecast (2021-2026)
    • 12.3.3 Europe: IVIG Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific IVIG Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: IVIG Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: IVIG Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: IVIG Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America IVIG Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: IVIG Sales Forecast (2021-2026)
    • 12.5.2 Latin America: IVIG Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: IVIG Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa IVIG Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: IVIG Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: IVIG Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: IVIG Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key IVIG Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 IVIG Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Summary:
    Get latest Market Research Reports on IVIG. Industry analysis & Market Report on IVIG is a syndicated market report, published as Global IVIG Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of IVIG market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,014.70
    4,522.05
    6,029.40
    3,630.90
    5,446.35
    7,261.80
    595,491.00
    893,236.50
    1,190,982.00
    329,160.00
    493,740.00
    658,320.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report